EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Treating microsatellite unstable metastatic parathyroid carcinoma with anti-PD1 therapy

Borna Amir-Kabirian iD, Radhwan AlRubaye, Benjamin Cadle, Daniel Mais, Zakaria Sibai, Rebecca Redman

JCEM Case Reports · 19.03.2026 · 4 (4)

DOI: 10.1210/jcemcr/luag045 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 24.03.2026. Verfasst von Borna Amir-Kabirian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Medical Oncology and Hematology, University of Louisville, 529 S Jackston St, Louisville, KY 40202, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parathyroid carcinoma (PC) is a rare endocrine malignancy that often clinically mimics primary hyperparathyroidism (PHPT) caused by parathyroid adenoma or hyperplasia. Complete resection of malignancy is the only curative treatment, and to date, there is no effective systemic therapy for advanced disease. A 60-year-old woman was referred for evaluation of hypercalcemia. Laboratory studies were consistent with PHPT. She underwent right superior parathyroidectomy, and pathology revealed PC with lymphovascular invasion. Postoperatively, calcium and parathyroid hormone levels normalized but recurred 6 months later. Imaging identified metastatic PC. Somatic genetic testing revealed a MutS homolog 2 (MSH2) splice-site mutation, indicating microsatellite instability. The patient started pembrolizumab immunotherapy, resulting in normalization of laboratory values and partial regression of metastases. This case highlights the diagnostic challenges of PC and underscores the potential role of immunotherapy in selected patients, particularly those with microsatellite instability, given the absence of established systemic treatment options.

Schlagwörter

Stichwörter der Autor:innen

immune checkpoint inhibitormicrosatellite instabilityparathyroid carcinoma

Autor:innen und Institutionen

  • Department of Medicine, Division of Medical Oncology and Hematology, University of Louisville, 529 S Jackston St, Louisville, KY 40202, USA.
  • Department of Medicine, Division of Endocrinology, University of Louisville, 550 S Jackson St, Louisville, KY 40202, USA.
  • University of Louisville School of Medicine, 323 E Chestnut Street, Louisville, KY 40202, USA.
  • Department of Pathology, University of Louisville, #23 E Chestnut Street, Louisville, KY 40202, USA.

ORCID-Profile: Borna Amir-Kabirian

Zitieren

APA

Amir-Kabirian, B., AlRubaye, R., Cadle, B., Mais, D., Sibai, Z., & Redman, R. (2026). Treating microsatellite unstable metastatic parathyroid carcinoma with anti-PD1 therapy. JCEM Case Reports, 4(4). https://doi.org/10.1210/jcemcr/luag045

Vancouver

Amir-Kabirian B, AlRubaye R, Cadle B, Mais D, Sibai Z, Redman R. Treating microsatellite unstable metastatic parathyroid carcinoma with anti-PD1 therapy. JCEM Case Reports. 2026;4(4). doi:10.1210/jcemcr/luag045

BibTeX
@article{AmirKabirian2026,
  author = {Amir-Kabirian, Borna and AlRubaye, Radhwan and Cadle, Benjamin and Mais, Daniel and Sibai, Zakaria and Redman, Rebecca},
  title = {Treating microsatellite unstable metastatic parathyroid carcinoma with anti-PD1 therapy},
  journal = {JCEM Case Reports},
  year = {2026},
  volume = {4},
  number = {4},
  doi = {10.1210/jcemcr/luag045}
}
Kostenlos starten →